Intermittent therapy with 6-mercaptopurine (NSC-755) and methotrexate (NSC-740) given intravenously to adults with acute leukemia
Ellison, R.R.; Hoogstraten, B.; Holland, J.F.; Levy, R.N.; Lee, S.L.; Silver, R.T.; Leone, L.A.; Cooper, T.; Oberfield, R.A.; Ten Pas, A.; Blom, J.; Jacquillat, C.; Haurani, F.
Cancer ChemoTherapy Reports 56(4): 535-542
1972
ISSN/ISBN: 0069-0112 PMID: 4507688 Document Number: 45469
Document emailed within 1 workday
Related Documents
Fujimoto, T.; Sasaki, K.; Goya, N. 1978: Maintenance therapy of intermittent high-dose methotrexate in acute childhood leukemia--4-year survivals Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 41(4): 810-812Leone, G.; Pagano, L.; Marra, R.; Landolfi, R.; Cudillo, L.; Storti, S.; Mango, G.; Alfano, G.; D'Onofrio, G. 1987: Combination of 6-mercaptopurine, vincristine, methotrexate, and prednisone in resistant or relapsed acute nonlymphoid leukemia Cancer Treatment Reports 71(7-8): 751-753
Gottlieb, J.A.; Serpick, A.A. 1970: Prolonged intravenous methotrexate therapy in the treatment of acute leukemia and solid tumors Cancer Research 30(8): 2132-2138
Ringdén, O.; Labopin, M.; Gluckman, E.; Reiffers, J.; Vernant, J.P.; Jouet, J.P.; Harrousseau, J.L.; Fiere, D.; Bacigalupo, A.; Frassoni, F.; Gorin, N.C. 1996: Graft-versus-leukemia effect in allogeneic marrow transplant recipients with acute leukemia is maintained using cyclosporin a combined with methotrexate as prophylaxis. Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation Bone Marrow Transplantation 18(5): 921-929
Isaev, V.G.; Savchenko, V.G.; Kucher, R.A.; Abakumov, E.M.; Parovichnikova, E.N. 1992: The programmed therapy of acute lymphoblastic leukemia in adults Terapevticheskii Arkhiv 64(8): 82-87
Bassan, R.; Barbui, T. 1995: Remission induction therapy for adults with acute myelogenous leukemia: towards the ICE age? Haematologica 80(1): 82-90
Hartwich, G.; Brandt, W.; Petzoldt, R. 1975: Results of therapy in acute leukemia in adults. Comparison of different combinations of cytotoxic drugs Medizinische Klinik 70(14): 622-625
Verdich, J.; Christensen, A.L. 1979: Pulmonary disease complicating intermittent methotrexate therapy of psoriasis Acta Dermato-Venereologica 59(5): 471-473
Rowe, J.M.; Andersen, J.W.; Cassileth, P.A.; Oken, M.M.; Bennett, J.M.; Wiernik, P.H. 1992: Post-remission therapy in adults with acute myelogenous leukemia: the Eastern Cooperative Oncology Group (ECOG) experience Leukemia 6(Suppl 4): 75-77
Komp, D.M.; Trueworthy, R.; Hvizdala, E.; Sexauer, C. 1979: Prednisolone, methotrexate, and 6-mercaptopurine in the treatment of histiocytosis X Cancer Treatment Reports 63(11-12): 2125-2126
Moriyama, Y.; Urushiyama, M.; Ohnishi, M.; Koyama, S.; Hirosawa, H.; Hanano, M.; Fuse, I.; Takai, K.; Nagayama, R.; Fujiwara, M.; Kishi, K.; Takahashi, M.; Koike, T.; Takahashi, H.; Sakai, C.; Aoyagi, Y.; Sanada, M.; Hattori, A.; Shibata, A. 1982: Infections during induction chemotherapy of acute leukemia and their control V. Clinical evaluation of a large dose of amikacin injected intravenously Japanese Journal of Antibiotics 35(6): 1579-1584
Taguchi, H.; Kubonishi, I.; Takehara, N.; Uemura, Y.; Iwahara, Y.; Eguchi, T.; Miyagi, T.; Sugito, S.; Muneishi, H.; Tanaka, Y. 1992: Intensive induction chemotherapy of adult acute myelogenous leukemia by continuing daunorubicin, behenoyl-cytosine arabinoside, 6-mercaptopurine and prednisolone until marrow aplasia Gan to Kagaku Ryoho. Cancer and ChemoTherapy 19(9): 1309-1314
Biukhner, T.; Khiddeman, V.; Mashmeĭer, G.; Liudvig, V.; Lëffler, K.; Novrusian, M.; Aul, S.; Kheĭneke, A. 1991: How to improve results of chemotherapy of acute myeloid leukemia in adults: research of the cooperative group for studying acute myeloid leukemia in West Germany Gematologiia i Transfuziologiia 36(9): 38-40
Tomić, D.; Bosković, D.; Beslać-Bumbasirević, L.; Rolović, Z. 1989: Central nervous system leukemia in adults with acute lymphoblastic leukemia Srpski Arhiv Za Celokupno Lekarstvo 117(11-12): 727-736
Lares-Asseff, I.; Paredes, R.; Taboada, C.; Cravioto, J.; Velázquez, M.; Roldán, R.M.; Faisal, A.G. 1988: Pharmacokinetics of methotrexate in children with acute lymphoblastic leukemia Boletin Medico del Hospital Infantil de Mexico 45(10): 671-680
Bertino, J.R.; Sawicki, W.L.; Cashmore, A.R.; Cadman, E.C.; Skeel, R.T. 1977: Natural resistance to methotrexate in human acute nonlymphocytic leukemia Cancer Treatment Reports 61(4): 667-673
Howell, S.B.; Carmody, J. 1977: Changes in glomerular filtration rate associated with high-dose methotrexate therapy in adults Cancer Treatment Reports 61(7): 1389-1391
Wang, J.J.; Freeman, A.I.; Sinks, L.F. 1976: Treatment of acute lymphocytic leukemia by high-dose intravenous methotrexate Cancer Research 36(4): 1441-1444
Storek, J. 1985: Therapy of leukemia in rats using a conjugate of specific immunoglobulin and albumin-methotrexate Sbornik Lekarsky 87(5): 121-127
Otterness, I.G.; Chang, Y.H. 1976: Comparative study of cyclophosphamide, 6-mercaptopurine, azathiopurine and methotrexate. Relative effects on the humoral and the cellular immune response in the mouse Clinical and Experimental Immunology 26(2): 346-354